Rebel Yell: Celgene (CELG) El Feugo Today
We recommended Celgene (CELG) in June of 2014 in Superstock Investor (Morning Matters Portfolio) at a price of $77.66 and it closed yesterday at $111.14. This afternoon it is back to $122.07.
The news is that the company settled patent litigation on Revlimid that allows for a generic in 2026.
News on Revlimid
Many of our names we hold for longer than a year so that if you are a reader of Superstock Investor then you can bank some real coin, not just chump change from trades that last a week or two.